Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Ze‐Ning Huang is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, with a particular emphasis on robotic versus laparoscopic gastrectomy. His major contributions include conducting landmark randomized controlled trials and large-scale propensity score-matched studies that rigorously compare the safety, efficacy, and oncological outcomes of these two approaches. Notably, his 2020 study on robotic versus laparoscopic distal gastrectomy has garnered 236 citations, establishing a benchmark in the field. Dr. Huang has also pioneered innovative techniques such as "Huang's three-step maneuver" for spleen-preserving splenic hilar lymphadenectomy, demonstrating superior short-term outcomes. His work consistently shows that robotic gastrectomy offers advantages in surgical precision, reduced blood loss, and faster recovery, while maintaining comparable long-term oncological results. With multiple publications exceeding 40 citations and a growing body of evidence from multicenter cohort studies, Dr. Huang’s research has significantly shaped clinical practice, providing surgeons with data-driven insights to optimize surgical care for gastric cancer patients.